IGM Biosciences Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
1.70
-0.01
(-0.58%)
Volume:
720,314
52 week range:
1.59 - 22.50
Market Cap:
101.089M
Company Description:
IGM Biosciences, Inc. develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma.